Previous investigations on CD38 expression in CTCL have been limited and somewhat inconsistent, particularly in Sézary Syndrome (SS) cells, which exhibited intermediate CD38 staining in treatment-resistant, aggressive CTCL subtypes [15, 18]. The gene discussed is CD38; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.